#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Kendall Anderson Email
Director Target Discovery . Envisagenics
New York, NY
LocationPrimary Email
How to contact Kendall Anderson
Join and see Kendall's contact info for free!Current Roles
Employees:
54Revenue:
$4.2MAbout
Envisagenics was founded in 2014 as a spinout of Cold Spring Harbor Laboratory. Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence. \n\nWe focus on the discovery of RNA therapeutics. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors, and more remain to be discovered.\n\nOur breakthrough technology, SpliceCore, is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data, using Artificial Intelligence. We are using our software to identify splicing errors causative of diseases, identify the right drug-targets and develop RNA therapeutics through partnerships and collaborations with Biopharma. Our in-silico RNA therapeutics discovery platform replaces expensive drug-target selection and lead design with efficient computer simulations, decreasing time, cost, and failure risk of drug development programs.Envisagenics Address
30-02 48th AveNew York, NY
United States